Preclinical validation of anti-TMEFF2-auristatin E-conjugated antibodies in the treatment of prostate cancer. (Q53889100)
Jump to navigation
Jump to search
scientific article
Language | Label | Description | Also known as |
---|---|---|---|
English | Preclinical validation of anti-TMEFF2-auristatin E-conjugated antibodies in the treatment of prostate cancer. |
scientific article |
Statements
Preclinical validation of anti-TMEFF2-auristatin E-conjugated antibodies in the treatment of prostate cancer (English)
Carlos Cordon-Cardo
Daniel E H Afar
Vinay Bhaskar
Eric Ibsen
Danna Breinberg
Susan M Henshall
Rick Powers
Melanie Wong
Ferdinand Evangelista
Chris O'Hara
David Powers
Robert B DuBridge
Ingrid Caras
Ruth Winter
Terri Anderson
Nanette Solvason
Phillip D Stricker
Howard I Scher
John J Grygiel
Robert L Sutherland
Richard Murray
Vanitha Ramakrishnan
Debbie A Law
1 August 2004